Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
AMRX
$20.07
-0.35%
AMRX
· Amneal Pharmaceuticals, Inc.
$20.07
-0.07 (-0.35%)
At close · Oct 1
Return incl. dividend (before tax)
Market Cap
$6.55B
Shares
319.35M
Volume · Oct 1
3.94M
Avg daily vol (3M)
2.14M
All webcasts
Earnings call · FY2019 Q4
Amneal Pharmaceuticals, Inc. (AMRX) Q4 2019 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$397.33M
-20.1% YoY
Diluted EPS
-$0.23
Gross margin
27.7%
-11.2 pp YoY
Net income
-$64.90M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Feb 26, 2020 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 2, 2020 · complete as-filed document